<DOC>
	<DOCNO>NCT02622659</DOCNO>
	<brief_summary>Randomized , double blind , double dummy , positive drug parallel comparison , multi-centre clinical trial ass efficacy safety Fuganlin Oral Liquid child influenza ( acute upper respiratory infection ) .</brief_summary>
	<brief_title>The Efficacy Safety Study Fuganlin Oral Liquid Children With Influenza ( Acute Upper Respiratory Infection )</brief_title>
	<detailed_description>Treatment group : Fuganlin Oral Liquid 10mL . Control group : Xiaoer Jiebiao oral liquid 100mL . Treatment one week . Patients recover within one week withdrawal time .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>1 . Patients diagnose acute upper respiratory infection . 2 . Patients Traditional Chinese Medicine syndrome qi deficiency windheat . 3 . Patients age 1 12 year . 4 . With course disease 48 hour less . 5 . Signed informed consent Parent legal guardian . 1 . Patients diagnose tonsillitis , bronchitis , bronchiolitis , pneumonia ; 2 . Patients history hyperpyretic convulsion ; 3 . Severe malnutrition , rickets patient merge heart , brain , liver , kidney hematopoietic system serious primary disease ; 4 . The increased serum creatinine ( Cr ) , blood urea nitrogen ( BUN ) , alanine aminotransferase ( ALT ) , urinary protein , urine RBC `` + '' , use test illness possibly combine disease condition explain ; 5 . Patients allergic physique ( Allergic two kind substance ) , allergic composition preparation control drug ; 6 . According doctor ' determination , likely loss follow .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>acute upper respiratory infection</keyword>
</DOC>